3,573,899 Shares of Common Stock And Warrants to Purchase 714,780 Shares of Common Stock Transgenomic, Inc. PURCHASE AGREEMENTPurchase Agreement • February 27th, 2015 • Transgenomic Inc • Laboratory analytical instruments • New York
Transgenomic, Inc., a Delaware corporation (the “Company”), proposes to sell to Craig-Hallum Capital Group LLC (“you” or the “Underwriter”) (i) an aggregate of 3,573,899 shares (the “Firm Shares”) of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company and (ii) warrants of the Company, in the form set forth in Exhibit A hereto, to purchase 714,780 shares (“Warrant Shares”) of Common Stock at an exercise price of $2.24 per share (the “Firm Warrants”). Each Firm Share is being sold together with a Firm Warrant to purchase 0.20 shares of Common Stock at an exercise price of $2.24 per share. The Firm Shares and Warrant Shares consist of authorized but unissued shares of Common Stock to be issued and sold by the Company. The Firm Shares, Firm Warrants and Warrant Shares purchased pursuant to this Purchase Agreement (the “Agreement”) are herein collectively called the “Securities.”
